CME Programme
-
Regular Activities
BackCME Hybrid Symposium on Diabetes Mellitus & Heart Failure - 1) SGLT2 Inhibition: Latest Evidence along the Cardio-renal-metabolic Axis 2) SGLT2 Inhibition across LVEF Spectrum: The Turning Point in HF HistoryDate: 10/06/2023 Enquiries: CME Department, The Hong Kong Medical Association CME Points Awarded: 2 points